Prospective Multicenter Registry Study Reports High Local Tumor Control Following Resection with GammaTile® in Newly Diagnosed Brain Metastases

GT Medical Technologies, Inc., a company focused on improving the lives of patients with brain tumors, today announced a publication of prospective, multicenter Phase IV data from the ongoing ...
WIBC 93.1 FM

Sleep Duration Directly Impacts Atrial Fibrillation Risk, Study Finds

Atrial fibrillation is the most common form of heart rhythm disorder and is linked to serious complications, including stroke and heart failure. While earlier research pointed to a possible ...

CereVasc, Inc. Announces Publication of A Multi-Center Study Evaluating the eShunt® System in the Treatment of Patients with NPH

CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...

Study identifies long-term health risks in testicular cancer survivors treated with contemporary chemotherapy

A large, multi-center study published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new insight into the long-term health effects of contemporary chemotherapy ...

Adagio Medical (ADGM) announces successful results from US cardiac ablation feasibility study

Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early ...
ascopubs.org

ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine ...

Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
ascopubs.org

A multi-center study on the role of ACSL4 in invasion and metastasis of hepatocellular carcinoma.

Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
Medical Dialogues

Romosozumab Boosts Bone Density in Postmenopausal Women Regardless of Age: Study Shows

Belgium: Researchers have reported that age does not appear to influence how postmenopausal women with osteoporosis respond to romosozumab therapy, based on real-world evidence from a ...